Candida auris-associated candidemia, South Africa.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMC 4073876)

Published in Emerg Infect Dis on July 01, 2014

Authors

Rindidzani E Magobo, Craig Corcoran, Sharona Seetharam, Nelesh P Govender

Articles citing this

Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. J Clin Microbiol (2015) 1.52

Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis (2015) 1.16

Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere (2016) 1.07

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis (2016) 0.99

First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control (2016) 0.91

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrob Agents Chemother (2017) 0.90

Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect (2016) 0.87

Candida haemulonii Complex Species, Brazil, January 2010-March 2015. Emerg Infect Dis (2016) 0.86

Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia. Emerg Infect Dis (2017) 0.85

Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India. Genome Announc (2015) 0.81

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis (2017) 0.80

Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist (2017) 0.79

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection. Antimicrob Agents Chemother (2017) 0.75

Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist (2017) 0.75

Rapid and accurate molecular identification of the emerging multidrug resistant pathogen Candida auris. J Clin Microbiol (2017) 0.75

In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris. Antimicrob Agents Chemother (2017) 0.75

Articles by these authors

A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med (2013) 4.14

HIV-1 subtype C seronegative AIDS. Clin Infect Dis (2008) 1.25

Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol (2012) 1.10

Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa. PLoS One (2011) 1.07

A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005-2007. AIDS (2012) 1.02

Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study. BMC Infect Dis (2011) 0.99

Analyses of pediatric isolates of Cryptococcus neoformans from South Africa. J Clin Microbiol (2010) 0.96

Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94

Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients. S Afr Med J (2016) 0.93

Systemic shigellosis in South Africa. Clin Infect Dis (2012) 0.90

The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention. S Afr Med J (2012) 0.90

The value of routine polymerase chain reaction analysis of intraocular fluid specimens in the diagnosis of infectious posterior uveitis. ScientificWorldJournal (2013) 0.86

The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. S Afr Med J (2016) 0.84

AIDS-related mycoses: the way forward. Trends Microbiol (2014) 0.80

Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis (2016) 0.79

Cryptococcal antigen screening in HIV-infected adults: let's get straight to the point. AIDS (2016) 0.78

An emmonsia species causing disseminated infection in South Africa. N Engl J Med (2014) 0.78

Access to flucytosine for HIV-infected patients with cryptococcal meningitis – an urgent need. S Afr Med J (2014) 0.77

HIV-associated disseminated emmonsiosis, Johannesburg, South Africa. Emerg Infect Dis (2014) 0.75

Clinical and microbiological features of invasive nontyphoidal Salmonella associated with HIV-infected patients, Gauteng Province, South Africa. Medicine (Baltimore) (2017) 0.75

Culture-negative endocarditis due to Bartonella quintana. S Afr Med J (2016) 0.75

Looking for fungi in all the right places: screening for cryptococcal disease and other AIDS-related mycoses among patients with advanced HIV disease. Curr Opin HIV AIDS (2017) 0.75

Serologic diagnosis of congenital rubella: a cautionary tale. Pediatr Infect Dis J (2005) 0.75